Wegovy News

Wegovy-maker Novo Nordisk partners with OpenAI to speed drug development - Reuters

Wegovy-maker Novo Nordisk partners with OpenAI to speed drug development Reuters

Wegovy Maker Novo Nordisk Strikes Deal With OpenAI to Speed Up Drug Discovery - WSJ

Wegovy Maker Novo Nordisk Strikes Deal With OpenAI to Speed Up Drug Discovery WSJ

The FDA approves a new obesity pill, giving patients another option - NPR

The FDA approves a new obesity pill, giving patients another option NPR

What Is 'Eye Stroke'? Expert Explains The Rare Wegovy Risk - ScienceAlert

What Is 'Eye Stroke'? Expert Explains The Rare Wegovy Risk ScienceAlert

Ozempic Is About to Go Generic for Billions of People - The New York Times

Ozempic Is About to Go Generic for Billions of People The New York Times

Novo Nordisk says Wegovy pill outperforms Lilly’s oral GLP-1 in cross-trial comparison - CNBC

Novo Nordisk says Wegovy pill outperforms Lilly’s oral GLP-1 in cross-trial comparison CNBC

Weight-loss jabs will be offered on NHS for people at risk of further heart attacks - bbc.com

Weight-loss jabs will be offered on NHS for people at risk of further heart attacks bbc.com

A new weight-loss pill is here. Here's how Foundayo compares to Wegovy, Zepbound, and other GLP-1 rivals. - Business Insider

A new weight-loss pill is here. Here's how Foundayo compares to Wegovy, Zepbound, and other GLP-1 rivals. Business Insider

Novo Nordisk launches first and only multi-month subscription program for FDA-approved Wegovy®, offering savings of up to $1,200/year - PR Newswire

Novo Nordisk launches first and only multi-month subscription program for FDA-approved Wegovy®, offering savings of up to $1,200/year PR Newswire

The weight-loss drug rivalry heats up as another GLP-1 pill gains FDA approval - Scientific American

The weight-loss drug rivalry heats up as another GLP-1 pill gains FDA approval Scientific American

Quit a GLP-1? Plan to start again? It's not recommended, but plenty of people do it - NPR

Quit a GLP-1? Plan to start again? It's not recommended, but plenty of people do it NPR

GLP-1 Weight-Loss Pills: What You Need to Know - Yale Medicine

GLP-1 Weight-Loss Pills: What You Need to Know Yale Medicine

Comparison of Oral Semaglutide (Wegovy) and Orforglipron (Foundayo) for the Treatment of Obesity and Overweight - Medical Professionals Reference

Comparison of Oral Semaglutide (Wegovy) and Orforglipron (Foundayo) for the Treatment of Obesity and Overweight Medical Professionals Reference

Ozempic, Wegovy: Why GLP-1 Drugs Don't Work for Everyone - Healthline

Ozempic, Wegovy: Why GLP-1 Drugs Don't Work for Everyone Healthline

How do weight-loss drugs like Mounjaro and Wegovy work? - bbc.com

How do weight-loss drugs like Mounjaro and Wegovy work? bbc.com

Novo Nordisk's Wegovy® HD available now nationwide - PR Newswire

Novo Nordisk's Wegovy® HD available now nationwide PR Newswire

Foundayo, Wegovy and how GLP-1 weight-loss pills compare to shots - USA Today

Foundayo, Wegovy and how GLP-1 weight-loss pills compare to shots USA Today

Wegovy Lawsuit 2025-26 | Gastroparesis & Wegovy Settlements - Sokolove Law

Wegovy Lawsuit 2025-26 | Gastroparesis & Wegovy Settlements Sokolove Law

Single-dose 7.2mg semaglutide (Wegovy) pen approved to treat adult patients with obesity - GOV.UK

Single-dose 7.2mg semaglutide (Wegovy) pen approved to treat adult patients with obesity GOV.UK

EXCLUSIVE: New Subscription Program for Wegovy Could Save Patients $1,200 a Year — How to Access It - TODAY.com

EXCLUSIVE: New Subscription Program for Wegovy Could Save Patients $1,200 a Year — How to Access It TODAY.com

FDA Approves Higher-Dose Wegovy To Help People Lose More Weight - Infectious Disease Advisor

FDA Approves Higher-Dose Wegovy To Help People Lose More Weight Infectious Disease Advisor

Maine doctor reacts to new GLP-1 pill by Wegovy - WMTW

Maine doctor reacts to new GLP-1 pill by Wegovy WMTW

Wegovy maker and OpenAI partnering to speed up search for new drugs - The Independent

Wegovy maker and OpenAI partnering to speed up search for new drugs The Independent

Wegovy Launches New Subscription—How to Save Up to $1,200 - Forbes

Wegovy Launches New Subscription—How to Save Up to $1,200 Forbes

Novo Nordisk's explosive Wegovy pill launch draws a new wave of patients into GLP-1 weight loss treatment - CNBC

Novo Nordisk's explosive Wegovy pill launch draws a new wave of patients into GLP-1 weight loss treatment CNBC

Some people don’t lose weight with GLP-1s. Evidence is building that the drugs are helping anyway - KSL TV 5

Some people don’t lose weight with GLP-1s. Evidence is building that the drugs are helping anyway KSL TV 5

UK approves Novo Nordisk single-dose 7.2mg Wegovy pen for obesity patients (NVO:NYSE) - Seeking Alpha

UK approves Novo Nordisk single-dose 7.2mg Wegovy pen for obesity patients (NVO:NYSE) Seeking Alpha

Novo Nordisk Launches Higher-Dose Wegovy Weight-Loss Shot in U.S. - WSJ

Novo Nordisk Launches Higher-Dose Wegovy Weight-Loss Shot in U.S. WSJ

America Has a New GLP-1 Playbook - The Atlantic

America Has a New GLP-1 Playbook The Atlantic

Wegovy maker and OpenAI partnering to speed up search for new drugs - AOL.com

Wegovy maker and OpenAI partnering to speed up search for new drugs AOL.com

Wegovy® pill demonstrated greater weight loss than orforglipron and lower odds of stopping medication due to side effects in a new indirect comparison to be presented at Obesity Medicine Association 2026 - PR Newswire

Wegovy® pill demonstrated greater weight loss than orforglipron and lower odds of stopping medication due to side effects in a new indirect comparison to be presented at Obesity Medicine Association 2026 PR Newswire

FDA asks Lilly for more safety data on weight loss pill Foundayo - NBC News

FDA asks Lilly for more safety data on weight loss pill Foundayo NBC News

Novo Nordisk launches higher-dose Wegovy in the United States - Reuters

Novo Nordisk launches higher-dose Wegovy in the United States Reuters

Wegovy-maker Novo Nordisk partners with OpenAI to speed drug development - Yahoo Finance

Wegovy-maker Novo Nordisk partners with OpenAI to speed drug development Yahoo Finance

Novo Nordisk A/S: Wegovy® injection becomes first GLP-1 weight-loss treatment approved for 48-hour controlled-temperature delivery in the EU - Yahoo Finance

Novo Nordisk A/S: Wegovy® injection becomes first GLP-1 weight-loss treatment approved for 48-hour controlled-temperature delivery in the EU Yahoo Finance